http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UY-29272-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C309-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C321-20 |
| filingDate | 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f19c18594f24ed1503665c140c876d7 |
| publicationDate | 2006-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UY-29272-A1 |
| titleOfInvention | THERAPEUTIC AGENTS |
| abstract | A cinconidine salt, a salt (R) - (+) -1- (1-naphthyl) ethylamine and a salt (S) - (-) - 1- (2-naphthyl) ethylamine acid (-) - 2- ( (2- (4-hydroxyphenyl) ethyl) thio) -3- (4- (4- (4 - ((methylsulfonyl) oxy) phenoxy) ethyl) phenyl) propanoic acid, the processes for its preparation, its use in the treatment of clinical ailments, including lipid disorders (dyslipidemia), associated or not with insulin resistance and other manifestations of metabolic syndrome, and the pharmaceutical compositions that contain them. |
| priorityDate | 2005-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.